Education
About Us
Working with TipRanks
Follow Us
euglena Co., Ltd. (JP:2931)
:2931
2931 Stock Chart & Stats
¥407.00
-¥7.00(-1.67%)
At close: 4:00 PM EST
¥407.00
-¥7.00(-1.67%)
Day’s Range― - ―
52-Week Range¥389.00 - ¥540.00
Previous CloseN/A
Volume629.20K
Average Volume (3M)958.05K
Market Cap
¥54.36B
Enterprise Value¥59.65B
Total Cash (Recent Filing)¥18.54B
Total Debt (Recent Filing)¥22.66B
Price to Earnings (P/E)―
Beta0.67
Next Earnings
May 08, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.11
Shares Outstanding136,599,260
10 Day Avg. Volume1,429,850
30 Day Avg. Volume958,053
Financial Highlights & Ratios
PEG Ratio-3.13
Price to Book (P/B)1.76
Price to Sales (P/S)1.08
P/FCF Ratio10.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue GrowthSustained revenue expansion over multiple years demonstrates durable commercial traction and scale in both consumer and B2B channels. Higher top-line provides capacity to absorb fixed costs, negotiate better supplier terms, fund R&D and marketing, and supports a continued investment-led growth strategy.
Operating Profitability RecoveryA shift to positive operating profit that improved in 2025 signals structural improvement in core margins and operational execution. Persistent operating profitability enables internal funding of growth initiatives, demonstrates scalable economics, and is a key step toward sustainable net profitability.
Strong Free Cash Flow GenerationMaterial free cash flow in 2025 reflects meaningful cash conversion from operations and improved cash discipline. Durable FCF reduces reliance on external financing, supports capex and commercialization, and provides a financial buffer while the company continues to close residual profitability gaps.
Bears Say
Ongoing Net Losses / Negative ROEPersisting net losses and negative ROE constrain retained earnings and shareholder returns despite operational gains. Until net profitability is consistently achieved, the company faces limits on dividend capacity, heightened scrutiny on capital allocation, and potential dilution risks if external capital is needed.
Modest Cash Conversion And Historical VolatilityA low operating cash flow coverage ratio indicates that a meaningful portion of revenue does not convert to cash, reducing earnings quality. Combined with earlier-period volatility in cash flows, this modest conversion increases sensitivity to margin pressure or working capital swings and weakens predictability of funding for growth.
Rising Absolute Debt Since 2023Although leverage ratios improved, rising absolute debt increases interest and refinancing burden, especially while net losses persist. Higher nominal debt can constrain strategic flexibility, elevate fixed financial costs, and create risk if cash generation falters or capital markets tighten, limiting long-term optionality.
euglena Co., Ltd. News
2931 FAQ
What was euglena Co., Ltd.’s price range in the past 12 months?
euglena Co., Ltd. lowest stock price was ¥389.00 and its highest was ¥540.00 in the past 12 months.
What is euglena Co., Ltd.’s market cap?
euglena Co., Ltd.’s market cap is ¥54.36B.
When is euglena Co., Ltd.’s upcoming earnings report date?
euglena Co., Ltd.’s upcoming earnings report date is May 08, 2026 which is in 77 days.
How were euglena Co., Ltd.’s earnings last quarter?
euglena Co., Ltd. released its earnings results on Feb 18, 2026. The company reported -¥3.11 earnings per share for the quarter, missing the consensus estimate of N/A by -¥3.11.
Is euglena Co., Ltd. overvalued?
According to Wall Street analysts euglena Co., Ltd.’s price is currently Overvalued.
Does euglena Co., Ltd. pay dividends?
euglena Co., Ltd. does not currently pay dividends.
What is euglena Co., Ltd.’s EPS estimate?
euglena Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does euglena Co., Ltd. have?
euglena Co., Ltd. has 136,599,260 shares outstanding.
What happened to euglena Co., Ltd.’s price movement after its last earnings report?
euglena Co., Ltd. reported an EPS of -¥3.11 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.251%.
Which hedge fund is a major shareholder of euglena Co., Ltd.?
Currently, no hedge funds are holding shares in JP:2931
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
euglena Co., Ltd.
Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae. It operates through Healthcare Business and Energy/Environment Business segments. The company also manufactures and sells foods and cosmetics using euglena. In addition, it offers health foods, beverages, confectionery, and sports food products. Further, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. It distributes its products at convenience stores, drugstores, supermarkets, beauty salons, and variety shops. The company was incorporated in 2005 and is headquartered in Tokyo, Japan.
Technical Analysis
Kao
―
Kobayashi Pharmaceutical Co
―
Kose
―
Rohto Pharmaceutical Co
―
Shiseido Company,Limited
―
Options Prices
Currently, No data available
---